Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: Determinants of survival

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 1, 1999, Pages

  Sadek, Ramses F ^a,b   Khan, Ali S ^a   Stevens, Gary ^a   Peters, C J ^a   Ksiazek, Thomas G ^a  

^a Ctr for Dis Ctrl and Prevention   (United States)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; BLOOD TRANSFUSION; CHILD; CONFERENCE PAPER; CONGO; EBOLA VIRUS; EPIDEMIC; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; VIRUS HEMORRHAGIC FEVER;

EID: 0033035994     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514311     Document Type: Conference Paper

References (17)

1. 1. Peters CJ, Sanchez A, Rollin P, Ksiazek T, Murphy F. Filoviridae: Marburg and Ebola viruses. In: Fields BN, Knipe DM, Howley PM, et al. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996: 1161-76.
2. 2. WHO/International Study Team. Ebola hemorrhagic fever in Sudan, 1976. Bull World Health Organ 1978; 56:247-70.
3. 3. WHO/International Commission. Ebola hemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978; 56:271-93.
4. 4. Heymann DL, Westfield JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 1980; 142:372-6.
5. 5. Ambland J, Obiang P, Edzang S, Prehaud C, Bouloy M, Le Guenno B. Identification of the Ebola virus in Gabon in 1994 [letter]. Lancet 1997; 349:181-2.
6. 6. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S76-86.
7. 7. Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999; 179(suppl 1);S18-23.
8. 8. Sadek RF, Khan AS, Kilmarx P, Ksiazek T, Peters CJ. Outbreak of Ebola hemorrhagic fever, Zaire, 1995: a closer numerical look. In: Proceedings of the Epidemiology section of the American Statistical Association (Anaheim, CA). Alexandria, VA: ASA, 1996:62-5.
9. 9. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesh C. Isolation and partial characterization of a new strain of Ebola virus. Lancet 1995; 345:1271-4.
10. 10. WHO. Ebola hemorrhagic fever confirmed case in Côte d'Ivoire and suspect cases in Liberia. Wkly Epidemiol Rec 1995; 70:359.
11. 11. WHO. Outbreak of hemorrhagic fever in Gabon officially declared over. Wkly Epidemiol Rec 1996; 71:125-6.
12. 12. Collet D. Modeling survival data in medical research. London: Chapman & Hall, 1995.
13. 13. Fisher DL, Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley & Sons, 1990.
14. 14. SAS Institute Inc. SAS /STAT user's guide. Vol. 2, version 6. Cary, NC: SAS Institute, 1990.
15. 15. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J infect Dis 1999; 179(suppl 1):S28-35.
16. 16. Selvan S. Statistical analysis of epidemiological data. 2nd ed. New York City: Oxford University Press, 1996.
17. 17. Maruyama T, Parren PWHI, Sanchez A, et el. Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis 1999; 179(suppl 1): S235-9.